Point72 Middle East Fze Karyopharm Therapeutics Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.68 - $1.31 $49,714 - $95,774
-73,110 Reduced 76.85%
22,028 $18,000
Q3 2023

Nov 14, 2023
BUY
$1.14 - $1.81 $10,493 - $16,661
9,205 Added 10.71%
95,138 $127,000
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $153,820 - $394,432
85,933 New
85,933 $153,000
Q4 2022

Feb 14, 2023
BUY
$2.48 - $5.93 $117,197 - $280,234
47,257 New
47,257 $0

Others Institutions Holding KPTI

# of Institutions
96
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email